18. Spinocerebellar degeneration Clinical trials / Disease details


Clinical trials : 71 Drugs : 99 - (DrugBank : 30) / Drug target genes : 45 - Drug target pathways : 65

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00229632
(ClinicalTrials.gov)
September 27, 200529/9/2005Idebenone to Treat Friedreich's AtaxiaA Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Efficacy of Idebenone Administered to Patients With Friedreich's AtaxiaFriedreich AtaxiaDrug: IdebenoneNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompleted9 Years17 YearsAll51Phase 2United States
2NCT00078481
(ClinicalTrials.gov)
February 200427/2/2004Phase 1 Trial of Idebenone to Treat Patients With Friedreich's AtaxiaPhase 1B Clinical Trial to Establish the Safety and Tolerability of a Multiple-Dose Regimen of Idebenone Administered to Patients With Friedreich's AtaxiaFriedreich AtaxiaDrug: IdebenoneNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompletedN/AN/ABoth16Phase 1United States
3NCT00015808
(ClinicalTrials.gov)
May 20016/5/2001Safety Study of Idebenone to Treat Friedreich's AtaxiaPhase I Clinical Trial to Establish the Maximum Tolerated Dose of Idebenone in Children, Adolescents, and Adults With Friedreich's AtaxiaFriedreich AtaxiaDrug: IdebenoneNational Institute of Neurological Disorders and Stroke (NINDS)NULLCompletedN/AN/ABoth100Phase 1United States